Global Protein Drugs Market Research Report 2023

Report ID: 1898899 | Published Date: Dec 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Protein Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Antibody Drugs
        1.2.3 Peptide Hormones
        1.2.4 Blood Products
        1.2.5 Enzymes
    1.3 Market by Application
        1.3.1 Global Protein Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Protein Drugs Market Perspective (2017-2028)
    2.2 Protein Drugs Growth Trends by Region
        2.2.1 Protein Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Protein Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Protein Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Protein Drugs Market Dynamics
        2.3.1 Protein Drugs Industry Trends
        2.3.2 Protein Drugs Market Drivers
        2.3.3 Protein Drugs Market Challenges
        2.3.4 Protein Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Protein Drugs Players by Revenue
        3.1.1 Global Top Protein Drugs Players by Revenue (2017-2022)
        3.1.2 Global Protein Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Protein Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Protein Drugs Revenue
    3.4 Global Protein Drugs Market Concentration Ratio
        3.4.1 Global Protein Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Protein Drugs Revenue in 2021
    3.5 Protein Drugs Key Players Head office and Area Served
    3.6 Key Players Protein Drugs Product Solution and Service
    3.7 Date of Enter into Protein Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Protein Drugs Breakdown Data by Type
    4.1 Global Protein Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Protein Drugs Forecasted Market Size by Type (2023-2028)
5 Protein Drugs Breakdown Data by Application
    5.1 Global Protein Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Protein Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Protein Drugs Market Size (2017-2028)
    6.2 North America Protein Drugs Market Size by Country (2017-2022)
    6.3 North America Protein Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Protein Drugs Market Size (2017-2028)
    7.2 Europe Protein Drugs Market Size by Country (2017-2022)
    7.3 Europe Protein Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Protein Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Protein Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Protein Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Protein Drugs Market Size (2017-2028)
    9.2 Latin America Protein Drugs Market Size by Country (2017-2022)
    9.3 Latin America Protein Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Protein Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Protein Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Protein Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Eli Lilly
        11.1.1 Eli Lilly Company Detail
        11.1.2 Eli Lilly Business Overview
        11.1.3 Eli Lilly Protein Drugs Introduction
        11.1.4 Eli Lilly Revenue in Protein Drugs Business (2017-2022)
        11.1.5 Eli Lilly Recent Development
    11.2 Abbott Laboratories
        11.2.1 Abbott Laboratories Company Detail
        11.2.2 Abbott Laboratories Business Overview
        11.2.3 Abbott Laboratories Protein Drugs Introduction
        11.2.4 Abbott Laboratories Revenue in Protein Drugs Business (2017-2022)
        11.2.5 Abbott Laboratories Recent Development
    11.3 UCB Group
        11.3.1 UCB Group Company Detail
        11.3.2 UCB Group Business Overview
        11.3.3 UCB Group Protein Drugs Introduction
        11.3.4 UCB Group Revenue in Protein Drugs Business (2017-2022)
        11.3.5 UCB Group Recent Development
    11.4 Schering-Plough Corporation
        11.4.1 Schering-Plough Corporation Company Detail
        11.4.2 Schering-Plough Corporation Business Overview
        11.4.3 Schering-Plough Corporation Protein Drugs Introduction
        11.4.4 Schering-Plough Corporation Revenue in Protein Drugs Business (2017-2022)
        11.4.5 Schering-Plough Corporation Recent Development
    11.5 Genentech
        11.5.1 Genentech Company Detail
        11.5.2 Genentech Business Overview
        11.5.3 Genentech Protein Drugs Introduction
        11.5.4 Genentech Revenue in Protein Drugs Business (2017-2022)
        11.5.5 Genentech Recent Development
    11.6 Johnson＆Johnson
        11.6.1 Johnson＆Johnson Company Detail
        11.6.2 Johnson＆Johnson Business Overview
        11.6.3 Johnson＆Johnson Protein Drugs Introduction
        11.6.4 Johnson＆Johnson Revenue in Protein Drugs Business (2017-2022)
        11.6.5 Johnson＆Johnson Recent Development
    11.7 Bristol-Myers Squibb
        11.7.1 Bristol-Myers Squibb Company Detail
        11.7.2 Bristol-Myers Squibb Business Overview
        11.7.3 Bristol-Myers Squibb Protein Drugs Introduction
        11.7.4 Bristol-Myers Squibb Revenue in Protein Drugs Business (2017-2022)
        11.7.5 Bristol-Myers Squibb Recent Development
    11.8 Novo Nordisk
        11.8.1 Novo Nordisk Company Detail
        11.8.2 Novo Nordisk Business Overview
        11.8.3 Novo Nordisk Protein Drugs Introduction
        11.8.4 Novo Nordisk Revenue in Protein Drugs Business (2017-2022)
        11.8.5 Novo Nordisk Recent Development
    11.9 Biogen Idec
        11.9.1 Biogen Idec Company Detail
        11.9.2 Biogen Idec Business Overview
        11.9.3 Biogen Idec Protein Drugs Introduction
        11.9.4 Biogen Idec Revenue in Protein Drugs Business (2017-2022)
        11.9.5 Biogen Idec Recent Development
    11.10 Dendreon Corporation
        11.10.1 Dendreon Corporation Company Detail
        11.10.2 Dendreon Corporation Business Overview
        11.10.3 Dendreon Corporation Protein Drugs Introduction
        11.10.4 Dendreon Corporation Revenue in Protein Drugs Business (2017-2022)
        11.10.5 Dendreon Corporation Recent Development
    11.11 Amgen Inc.
        11.11.1 Amgen Inc. Company Detail
        11.11.2 Amgen Inc. Business Overview
        11.11.3 Amgen Inc. Protein Drugs Introduction
        11.11.4 Amgen Inc. Revenue in Protein Drugs Business (2017-2022)
        11.11.5 Amgen Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Protein Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Antibody Drugs
    Table 3. Key Players of Peptide Hormones
    Table 4. Key Players of Blood Products
    Table 5. Key Players of Enzymes
    Table 6. Global Protein Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Protein Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Protein Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Protein Drugs Market Share by Region (2017-2022)
    Table 10. Global Protein Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Protein Drugs Market Share by Region (2023-2028)
    Table 12. Protein Drugs Market Trends
    Table 13. Protein Drugs Market Drivers
    Table 14. Protein Drugs Market Challenges
    Table 15. Protein Drugs Market Restraints
    Table 16. Global Protein Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Protein Drugs Market Share by Players (2017-2022)
    Table 18. Global Top Protein Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Drugs as of 2021)
    Table 19. Ranking of Global Top Protein Drugs Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Protein Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Protein Drugs Product Solution and Service
    Table 23. Date of Enter into Protein Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Protein Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Protein Drugs Revenue Market Share by Type (2017-2022)
    Table 27. Global Protein Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Protein Drugs Revenue Market Share by Type (2023-2028)
    Table 29. Global Protein Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Protein Drugs Revenue Market Share by Application (2017-2022)
    Table 31. Global Protein Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Protein Drugs Revenue Market Share by Application (2023-2028)
    Table 33. North America Protein Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Protein Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Protein Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Protein Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Protein Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Protein Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Protein Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Protein Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Protein Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Protein Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Eli Lilly Company Detail
    Table 44. Eli Lilly Business Overview
    Table 45. Eli Lilly Protein Drugs Product
    Table 46. Eli Lilly Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
    Table 47. Eli Lilly Recent Development
    Table 48. Abbott Laboratories Company Detail
    Table 49. Abbott Laboratories Business Overview
    Table 50. Abbott Laboratories Protein Drugs Product
    Table 51. Abbott Laboratories Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
    Table 52. Abbott Laboratories Recent Development
    Table 53. UCB Group Company Detail
    Table 54. UCB Group Business Overview
    Table 55. UCB Group Protein Drugs Product
    Table 56. UCB Group Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
    Table 57. UCB Group Recent Development
    Table 58. Schering-Plough Corporation Company Detail
    Table 59. Schering-Plough Corporation Business Overview
    Table 60. Schering-Plough Corporation Protein Drugs Product
    Table 61. Schering-Plough Corporation Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
    Table 62. Schering-Plough Corporation Recent Development
    Table 63. Genentech Company Detail
    Table 64. Genentech Business Overview
    Table 65. Genentech Protein Drugs Product
    Table 66. Genentech Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
    Table 67. Genentech Recent Development
    Table 68. Johnson＆Johnson Company Detail
    Table 69. Johnson＆Johnson Business Overview
    Table 70. Johnson＆Johnson Protein Drugs Product
    Table 71. Johnson＆Johnson Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
    Table 72. Johnson＆Johnson Recent Development
    Table 73. Bristol-Myers Squibb Company Detail
    Table 74. Bristol-Myers Squibb Business Overview
    Table 75. Bristol-Myers Squibb Protein Drugs Product
    Table 76. Bristol-Myers Squibb Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
    Table 77. Bristol-Myers Squibb Recent Development
    Table 78. Novo Nordisk Company Detail
    Table 79. Novo Nordisk Business Overview
    Table 80. Novo Nordisk Protein Drugs Product
    Table 81. Novo Nordisk Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
    Table 82. Novo Nordisk Recent Development
    Table 83. Biogen Idec Company Detail
    Table 84. Biogen Idec Business Overview
    Table 85. Biogen Idec Protein Drugs Product
    Table 86. Biogen Idec Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
    Table 87. Biogen Idec Recent Development
    Table 88. Dendreon Corporation Company Detail
    Table 89. Dendreon Corporation Business Overview
    Table 90. Dendreon Corporation Protein Drugs Product
    Table 91. Dendreon Corporation Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
    Table 92. Dendreon Corporation Recent Development
    Table 93. Amgen Inc. Company Detail
    Table 94. Amgen Inc. Business Overview
    Table 95. Amgen Inc. Protein DrugsProduct
    Table 96. Amgen Inc. Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
    Table 97. Amgen Inc. Recent Development
    Table 98. Research Programs/Design for This Report
    Table 99. Key Data Information from Secondary Sources
    Table 100. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Protein Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Antibody Drugs Features
    Figure 3. Peptide Hormones Features
    Figure 4. Blood Products Features
    Figure 5. Enzymes Features
    Figure 6. Global Protein Drugs Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Other Case Studies
    Figure 10. Protein Drugs Report Years Considered
    Figure 11. Global Protein Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Protein Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Protein Drugs Market Share by Region: 2021 VS 2028
    Figure 14. Global Protein Drugs Market Share by Players in 2021
    Figure 15. Global Top Protein Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Drugs as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Protein Drugs Revenue in 2021
    Figure 17. North America Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Protein Drugs Market Share by Country (2017-2028)
    Figure 19. United States Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Protein Drugs Market Share by Country (2017-2028)
    Figure 23. Germany Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Protein Drugs Market Share by Region (2017-2028)
    Figure 31. China Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Protein Drugs Market Share by Country (2017-2028)
    Figure 39. Mexico Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Protein Drugs Market Share by Country (2017-2028)
    Figure 43. Turkey Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Eli Lilly Revenue Growth Rate in Protein Drugs Business (2017-2022)
    Figure 46. Abbott Laboratories Revenue Growth Rate in Protein Drugs Business (2017-2022)
    Figure 47. UCB Group Revenue Growth Rate in Protein Drugs Business (2017-2022)
    Figure 48. Schering-Plough Corporation Revenue Growth Rate in Protein Drugs Business (2017-2022)
    Figure 49. Genentech Revenue Growth Rate in Protein Drugs Business (2017-2022)
    Figure 50. Johnson＆Johnson Revenue Growth Rate in Protein Drugs Business (2017-2022)
    Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Protein Drugs Business (2017-2022)
    Figure 52. Novo Nordisk Revenue Growth Rate in Protein Drugs Business (2017-2022)
    Figure 53. Biogen Idec Revenue Growth Rate in Protein Drugs Business (2017-2022)
    Figure 54. Dendreon Corporation Revenue Growth Rate in Protein Drugs Business (2017-2022)
    Figure 55. Amgen Inc. Revenue Growth Rate in Protein Drugs Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
Abbott Laboratories
UCB Group
Schering-Plough Corporation
Genentech
Johnson＆Johnson
Bristol-Myers Squibb
Novo Nordisk
Biogen Idec
Dendreon Corporation
Amgen Inc.
Frequently Asked Questions
Protein Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Protein Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Protein Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Psoriasis Drugs

Psoriasis Drugs market is segmented by players, region (country), by Type and by Application. Pla ... Read More